FDA Inspection 1236121 — Edward Czerwinski, MD, PhD
The FDA completed an inspection of Edward Czerwinski, MD, PhD on Mar 21, 2024 in Cracow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 21, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cracow (Poland)
Additional Details
Clinical Investigator (CI)